Mucocutaneous Leishmaniasis

DBCOND0051127InfectionsSkin and Subcutaneous Tissue Diseases

Mucocutaneous Leishmaniasis is the indication for 3 drugs in DrugBank. It is covered by 3 curated, structured indications.

Also known as
Leishmaniasis, Mucocutaneous · Mucosal Leishmaniasis
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0012334ICD-10B55.2SNOMED CT39625001MedDRA10023518UMLSC0023288

What you can answer from here — as of November 01, 2026

3Indicated drugsWith each drug's targets and mechanism
Listed above
3Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
18Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for Mucocutaneous Leishmaniasis share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In